The polymer biomaterial market size has grown rapidly in recent years. It will grow from $94.98 billion in 2025 to $109.73 billion in 2026 at a compound annual growth rate (CAGR) of 15.5%. The growth in the historic period can be attributed to growth in orthopedic procedures, expansion of dental implants, rising cardiovascular surgeries, increased plastic surgery demand, adoption of synthetic materials.
The polymer biomaterial market size is expected to see rapid growth in the next few years. It will grow to $197.22 billion in 2030 at a compound annual growth rate (CAGR) of 15.8%. The growth in the forecast period can be attributed to growth in regenerative medicine, increasing chronic diseases, expansion of implant technologies, rising demand for biodegradable materials, advancements in polymer chemistry. Major trends in the forecast period include rising demand for biocompatible polymers, growth of implantable medical devices, increasing use of synthetic biomaterials, expansion of tissue engineering applications, development of long-term durable polymers.
The increasing number of chronic diseases is increasingly supporting the expansion of the polymer biomaterial market going forward. Chronic diseases, also referred to as non-communicable diseases, are long-term conditions that persist over extended periods and often progress gradually. Polymer biomaterials are widely used in the development of implantable medical devices such as drug delivery pumps and neuromodulation electrodes. These applications help manage symptoms and enhance patient quality of life by providing long-term therapeutic support. For example, in June 2024, according to the National Health Service, a UK-based publicly funded healthcare system, 3,615,330 individuals registered with a general practitioner were identified as having non-diabetic hyperglycemia in 2023, reflecting an 18% increase compared to 2022. As a result, the rising prevalence of chronic diseases is reinforcing growth in the polymer biomaterial market.
Leading companies operating in the polymer biomaterial market are innovating new technologies, such as designed enzymatic biomaterials (DEB) technology, to improve performance and expand commercial opportunities. Designed enzymatic biomaterials technology represents a novel platform for producing high-performance polysaccharides through enzymatic processes. For example, in June 2023, International Flavors & Fragrances Inc., a US-based flavor and cosmetic ingredients company, launched its Enzymatic Biomaterials (DEB) technology. This sustainable biopolymer platform enables the production of biopolymers with performance characteristics comparable to petroleum-based polymers. The technology allows customization and fine-tuning of material properties by transferring functional attributes of petroleum-derived polymers into biopolymer components, supporting the development of sustainable, high-performance materials.
In July 2023, Biocoat, a US-based company focused on biocompatible coatings for medical devices, acquired Chempilots for an undisclosed amount. Through this acquisition, Biocoat sought to strengthen its polymer development capabilities and expand its range of biomedical product offerings. Chempilots is a Denmark-based company known for advanced polymer solutions that support the development of innovative medical technologies.
Major companies operating in the polymer biomaterial market are BASF SE, Corbion N.V., Zimmer Biomet Holdings Inc., Royal DSM N.V., Covestro AG, Evonik Industries AG, Starch Medical Inc., Victrex plc, W. L. Gore and Associates Inc., DSM Biomedical B.V., Purac Biomaterials, Ticona LLC, Invibo LLC, Covalon Technologies Ltd., Osteotech Inc., Medtronic plc, Stryker Corporation, Synthes Inc., Polyfibre Industries Pte Ltd., Toray Industries Inc., Stein Fibers Ltd., Bezwada Biomedical LLC, Collagen Solutions plc, Gelita AG, AorTech Biomaterials Pty Ltd., Berkeley Advanced Biomaterials Inc., Biocomposites Ltd., BioHorizons IPH Inc., Biomerics LLC, Bioteque Corporation, CollPlant Holdings Ltd., EndoShape Inc., PolyNovo Biomaterials Pty Ltd., Secant Group LLC.
North America was the largest region in the polymer biomaterials market in 2025. Western Europe was the second-largest region in the global polymer biomaterials market report. The regions covered in the polymer biomaterial market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the polymer biomaterial market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have increased the cost of imported medical grade polymers, additives, and processing equipment used in polymer biomaterials, creating pricing and supply challenges across the market. These impacts are most visible in high performance segments such as cardiovascular, ophthalmology, and tissue engineering applications, particularly in Europe and Asia where a large share of raw materials is sourced internationally. The resulting cost pressures have affected manufacturers’ margins and slowed procurement cycles for hospitals and medical device companies. However, tariffs have also encouraged local production of polymer resins and compounding activities, supporting regional supply chains and improving long term cost stability for polymer biomaterial suppliers.
The polymer biomaterial market research report is one of a series of new reports that provides polymer biomaterial market statistics, including polymer biomaterial industry global market size, regional shares, competitors with a polymer biomaterial market share, detailed polymer biomaterial market segments, market trends and opportunities, and any further data you may need to thrive in the polymer biomaterial industry. This polymer biomaterial market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Polymer biomaterials are non-reactive pharmacological materials derived from natural or synthetic sources. They are used to improve the performance of damaged tissues and organs involved in various therapeutic treatments.
The primary types of polymer biomaterials include silicone rubber, polyester, polymethyl methacrylate (PMMA), polyethylene (PE), polyvinyl chloride, and others. Silicone rubber in polymer biomaterials refers to a rubber matrix lightly cross-linked with a polyacrylamide hydrogel and used for medical and biological applications. The material nature includes natural and synthetic forms. Polymer biomaterials are applied in cardiovascular care, ophthalmology, dentistry, plastic surgery, wound healing, tissue engineering, orthopedics, neurological and central nervous system disorders, and others.
The polymer biomaterials market consists of sales of PCL, PVDF, PLGA, PVP, and nylon. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The polymer biomaterial market size is expected to see rapid growth in the next few years. It will grow to $197.22 billion in 2030 at a compound annual growth rate (CAGR) of 15.8%. The growth in the forecast period can be attributed to growth in regenerative medicine, increasing chronic diseases, expansion of implant technologies, rising demand for biodegradable materials, advancements in polymer chemistry. Major trends in the forecast period include rising demand for biocompatible polymers, growth of implantable medical devices, increasing use of synthetic biomaterials, expansion of tissue engineering applications, development of long-term durable polymers.
The increasing number of chronic diseases is increasingly supporting the expansion of the polymer biomaterial market going forward. Chronic diseases, also referred to as non-communicable diseases, are long-term conditions that persist over extended periods and often progress gradually. Polymer biomaterials are widely used in the development of implantable medical devices such as drug delivery pumps and neuromodulation electrodes. These applications help manage symptoms and enhance patient quality of life by providing long-term therapeutic support. For example, in June 2024, according to the National Health Service, a UK-based publicly funded healthcare system, 3,615,330 individuals registered with a general practitioner were identified as having non-diabetic hyperglycemia in 2023, reflecting an 18% increase compared to 2022. As a result, the rising prevalence of chronic diseases is reinforcing growth in the polymer biomaterial market.
Leading companies operating in the polymer biomaterial market are innovating new technologies, such as designed enzymatic biomaterials (DEB) technology, to improve performance and expand commercial opportunities. Designed enzymatic biomaterials technology represents a novel platform for producing high-performance polysaccharides through enzymatic processes. For example, in June 2023, International Flavors & Fragrances Inc., a US-based flavor and cosmetic ingredients company, launched its Enzymatic Biomaterials (DEB) technology. This sustainable biopolymer platform enables the production of biopolymers with performance characteristics comparable to petroleum-based polymers. The technology allows customization and fine-tuning of material properties by transferring functional attributes of petroleum-derived polymers into biopolymer components, supporting the development of sustainable, high-performance materials.
In July 2023, Biocoat, a US-based company focused on biocompatible coatings for medical devices, acquired Chempilots for an undisclosed amount. Through this acquisition, Biocoat sought to strengthen its polymer development capabilities and expand its range of biomedical product offerings. Chempilots is a Denmark-based company known for advanced polymer solutions that support the development of innovative medical technologies.
Major companies operating in the polymer biomaterial market are BASF SE, Corbion N.V., Zimmer Biomet Holdings Inc., Royal DSM N.V., Covestro AG, Evonik Industries AG, Starch Medical Inc., Victrex plc, W. L. Gore and Associates Inc., DSM Biomedical B.V., Purac Biomaterials, Ticona LLC, Invibo LLC, Covalon Technologies Ltd., Osteotech Inc., Medtronic plc, Stryker Corporation, Synthes Inc., Polyfibre Industries Pte Ltd., Toray Industries Inc., Stein Fibers Ltd., Bezwada Biomedical LLC, Collagen Solutions plc, Gelita AG, AorTech Biomaterials Pty Ltd., Berkeley Advanced Biomaterials Inc., Biocomposites Ltd., BioHorizons IPH Inc., Biomerics LLC, Bioteque Corporation, CollPlant Holdings Ltd., EndoShape Inc., PolyNovo Biomaterials Pty Ltd., Secant Group LLC.
North America was the largest region in the polymer biomaterials market in 2025. Western Europe was the second-largest region in the global polymer biomaterials market report. The regions covered in the polymer biomaterial market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the polymer biomaterial market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have increased the cost of imported medical grade polymers, additives, and processing equipment used in polymer biomaterials, creating pricing and supply challenges across the market. These impacts are most visible in high performance segments such as cardiovascular, ophthalmology, and tissue engineering applications, particularly in Europe and Asia where a large share of raw materials is sourced internationally. The resulting cost pressures have affected manufacturers’ margins and slowed procurement cycles for hospitals and medical device companies. However, tariffs have also encouraged local production of polymer resins and compounding activities, supporting regional supply chains and improving long term cost stability for polymer biomaterial suppliers.
The polymer biomaterial market research report is one of a series of new reports that provides polymer biomaterial market statistics, including polymer biomaterial industry global market size, regional shares, competitors with a polymer biomaterial market share, detailed polymer biomaterial market segments, market trends and opportunities, and any further data you may need to thrive in the polymer biomaterial industry. This polymer biomaterial market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Polymer biomaterials are non-reactive pharmacological materials derived from natural or synthetic sources. They are used to improve the performance of damaged tissues and organs involved in various therapeutic treatments.
The primary types of polymer biomaterials include silicone rubber, polyester, polymethyl methacrylate (PMMA), polyethylene (PE), polyvinyl chloride, and others. Silicone rubber in polymer biomaterials refers to a rubber matrix lightly cross-linked with a polyacrylamide hydrogel and used for medical and biological applications. The material nature includes natural and synthetic forms. Polymer biomaterials are applied in cardiovascular care, ophthalmology, dentistry, plastic surgery, wound healing, tissue engineering, orthopedics, neurological and central nervous system disorders, and others.
The polymer biomaterials market consists of sales of PCL, PVDF, PLGA, PVP, and nylon. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Polymer Biomaterial Market Characteristics
3. Polymer Biomaterial Market Supply Chain Analysis
4. Global Polymer Biomaterial Market Trends and Strategies
5. Polymer Biomaterial Market Analysis of End Use Industries
7. Global Polymer Biomaterial Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Polymer Biomaterial Total Addressable Market (TAM) Analysis for the Market
9. Polymer Biomaterial Market Segmentation
10. Polymer Biomaterial Market Regional and Country Analysis
11. Asia-Pacific Polymer Biomaterial Market
12. China Polymer Biomaterial Market
13. India Polymer Biomaterial Market
14. Japan Polymer Biomaterial Market
15. Australia Polymer Biomaterial Market
16. Indonesia Polymer Biomaterial Market
17. South Korea Polymer Biomaterial Market
18. Taiwan Polymer Biomaterial Market
19. South East Asia Polymer Biomaterial Market
20. Western Europe Polymer Biomaterial Market
21. UK Polymer Biomaterial Market
22. Germany Polymer Biomaterial Market
23. France Polymer Biomaterial Market
24. Italy Polymer Biomaterial Market
25. Spain Polymer Biomaterial Market
26. Eastern Europe Polymer Biomaterial Market
27. Russia Polymer Biomaterial Market
28. North America Polymer Biomaterial Market
29. USA Polymer Biomaterial Market
30. Canada Polymer Biomaterial Market
31. South America Polymer Biomaterial Market
32. Brazil Polymer Biomaterial Market
33. Middle East Polymer Biomaterial Market
34. Africa Polymer Biomaterial Market
36. Polymer Biomaterial Market Competitive Landscape and Company Profiles
37. Polymer Biomaterial Market Other Major and Innovative Companies
40. Polymer Biomaterial Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Polymer Biomaterial Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses polymer biomaterial market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for polymer biomaterial? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The polymer biomaterial market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Nylon; Silicone Rubber; Polyester; Polymethyl Methacrylate (PMMA); Polyethylene (PE); Polyvinyl Chloride; Other Types2) By Nature: Natural; Synthetic
3) By Application: Cardiovascular; Ophthalmology; Dental; Plastic Surgery; Wound Healing; Tissue Engineering; Orthopedics; Neurological Disorders Or Central Nervous System; Other Applications
Subsegments:
1) By Nylon: Nylon 6; Nylon 662) By Silicone Rubber: Liquid Silicone Rubber (LSR); Solid Silicone Rubber (SSR)
3) By Polyester: Polyethylene Terephthalate (PET); Polybutylene Terephthalate (PBT)
4) By Polymethyl Methacrylate (PMMA): Clear PMMA; Colored PMMA
5) By Polyethylene (PE): High-Density Polyethylene (HDPE); Low-Density Polyethylene (LDPE); Linear Low-Density Polyethylene (LLDPE)
6) By Polyvinyl Chloride: Rigid PVC; Flexible PVC
7) By Other Types: Polyurethane (PU); Polycarbonate (PC)
Companies Mentioned: BASF SE; Corbion N.V.; Zimmer Biomet Holdings Inc.; Royal DSM N.V.; Covestro AG; Evonik Industries AG; Starch Medical Inc.; Victrex plc; W. L. Gore and Associates Inc.; DSM Biomedical B.V.; Purac Biomaterials; Ticona LLC; Invibo LLC; Covalon Technologies Ltd.; Osteotech Inc.; Medtronic plc; Stryker Corporation; Synthes Inc.; Polyfibre Industries Pte Ltd.; Toray Industries Inc.; Stein Fibers Ltd.; Bezwada Biomedical LLC; Collagen Solutions plc; Gelita AG; AorTech Biomaterials Pty Ltd.; Berkeley Advanced Biomaterials Inc.; Biocomposites Ltd.; BioHorizons IPH Inc.; Biomerics LLC; Bioteque Corporation; CollPlant Holdings Ltd.; EndoShape Inc.; PolyNovo Biomaterials Pty Ltd.; Secant Group LLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Polymer Biomaterial market report include:- BASF SE
- Corbion N.V.
- Zimmer Biomet Holdings Inc.
- Royal DSM N.V.
- Covestro AG
- Evonik Industries AG
- Starch Medical Inc.
- Victrex plc
- W. L. Gore and Associates Inc.
- DSM Biomedical B.V.
- Purac Biomaterials
- Ticona LLC
- Invibo LLC
- Covalon Technologies Ltd.
- Osteotech Inc.
- Medtronic plc
- Stryker Corporation
- Synthes Inc.
- Polyfibre Industries Pte Ltd.
- Toray Industries Inc.
- Stein Fibers Ltd.
- Bezwada Biomedical LLC
- Collagen Solutions plc
- Gelita AG
- AorTech Biomaterials Pty Ltd.
- Berkeley Advanced Biomaterials Inc.
- Biocomposites Ltd.
- BioHorizons IPH Inc.
- Biomerics LLC
- Bioteque Corporation
- CollPlant Holdings Ltd.
- EndoShape Inc.
- PolyNovo Biomaterials Pty Ltd.
- Secant Group LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 109.73 Billion |
| Forecasted Market Value ( USD | $ 197.22 Billion |
| Compound Annual Growth Rate | 15.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 35 |
